LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.46 | 27.76 | 6 | 438 | 0.0137 | -0.3193 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.46 | 27.76 | 1097 | 438 | 2.5009 | 1.5177 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.46 | 27.76 | 5 | 438 | 0.0114 | -0.3498 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.46 | 27.76 | 1065 | 438 | 2.4279 | 1.4990 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.46 | 27.76 | 1014 | 438 | 2.3117 | 1.4684 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 23 | 489 | 0.0470 | -0.0444 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 923 | 489 | 1.8872 | 1.3317 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 11 | 489 | 0.0225 | -0.2004 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 1201 | 489 | 2.4557 | 1.4848 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 8 | 489 | 0.0164 | -0.2596 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 1125 | 489 | 2.3003 | 1.4459 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 5 | 489 | 0.0102 | -0.3391 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.17 | 27.76 | 1066 | 489 | 2.1796 | 1.4143 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 24 | 604 | 0.0397 | -0.0322 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 981 | 604 | 1.6223 | 1.2300 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 20 | 604 | 0.0331 | -0.0711 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 1280 | 604 | 2.1167 | 1.3675 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 159 | 604 | 0.2629 | 0.4809 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 1230 | 604 | 2.0340 | 1.3464 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 13.87 | 27.76 | 1120 | 604 | 1.8521 | 1.2974 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 45 | 685 | 0.0656 | 0.1101 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 1033 | 685 | 1.5068 | 1.1853 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 15.58 | 27.76 | 24 | 685 | 0.0350 | -0.0310 | MN20160318_Q01 | J19 |